Literature DB >> 27423206

Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis.

Han Cen1,2, Hua Huang3, Li-Na Zhang1,2, Li-Ya Liu1,2, Li Zhou3, Xia-Fei Xin3, Ren-Jie Zhuo4,5.   

Abstract

The aim of our study was to conduct a meta-analysis to assess whether combined evidence shows associations between C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and genetic susceptibility to rheumatoid arthritis (RA). A total of 11 articles involving 20 comparisons were included, containing 12 comparisons for the MTHFR C677T polymorphism and 8 comparisons for the MTHFR A1298C polymorphism. Significant evidence was detected for the association of RA susceptibility with the MTHFR C677T polymorphism T allele under allelic contrast and dominant model in Asians (T versus C, OR = 1.300, 95 % CI = 1.104-1.531, p = 0.002; TT + CT versus CC, OR = 1.495, 95 % CI = 1.187-1.882, p = 0.001). Significant association between RA susceptibility and the MTHFR A1298C polymorphism A allele under recessive model was found in the overall meta-analysis (AA versus AC + CC, OR = 1.281, 95 % CI = 1.048-1.565, p = 0.016). Our meta-analysis results demonstrate that the MTHFR C677T polymorphism is involved in the genetic susceptibility of RA in Asians, and the MTHFR A1298C polymorphism is associated with genetic susceptibility to RA in the overall population. Given the paucity of studies, especially in non-Asian populations, further studies with larger sample sizes are required to elucidate the role of MTHFR polymorphisms in the genetic basis of RA in different ethnic populations.

Entities:  

Keywords:  Meta-analysis; Methylenetetrahydrofolate reductase; Polymorphism; Rheumatoid arthritis

Mesh:

Substances:

Year:  2016        PMID: 27423206     DOI: 10.1007/s10067-016-3348-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  45 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

3.  Relationship between homocysteine and body mass index in rheumatoid arthritis.

Authors:  D J Armstrong; A D Quinn; E M McCausland; M B Finch; G D Wright
Journal:  Scand J Rheumatol       Date:  2007 May-Jun       Impact factor: 3.641

Review 4.  Epigenetics in rheumatoid arthritis.

Authors:  Kerstin Klein; Steffen Gay
Journal:  Curr Opin Rheumatol       Date:  2015-01       Impact factor: 5.006

5.  Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis.

Authors:  M A Lopez-Olivo; L Gonzalez-Lopez; A Garcia-Gonzalez; A I Villa-Manzano; A R Cota-Sanchez; M Salazar-Paramo; E Varon-Villalpando; E G Cardona-Muñoz; J I Gamez-Nava
Journal:  Scand J Rheumatol       Date:  2006 Mar-Apr       Impact factor: 3.641

6.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Authors:  N M van der Put; F Gabreëls; E M Stevens; J A Smeitink; F J Trijbels; T K Eskes; L P van den Heuvel; H J Blom
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

7.  A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations.

Authors:  G Friedman; N Goldschmidt; Y Friedlander; A Ben-Yehuda; J Selhub; S Babaey; M Mendel; M Kidron; H Bar-On
Journal:  J Nutr       Date:  1999-09       Impact factor: 4.798

8.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity.

Authors:  I Weisberg; P Tran; B Christensen; S Sibani; R Rozen
Journal:  Mol Genet Metab       Date:  1998-07       Impact factor: 4.797

9.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

Authors:  S S Kang; J Zhou; P W Wong; J Kowalisyn; G Strokosch
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

10.  Genetic Case-Control Study for Eight Polymorphisms Associated with Rheumatoid Arthritis.

Authors:  Mohamed N Saad; Mai S Mabrouk; Ayman M Eldeib; Olfat G Shaker
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

View more
  9 in total

1.  Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Yi Yuan; Wenjing Shao; Yuying Li
Journal:  Rheumatol Int       Date:  2017-02-07       Impact factor: 2.631

2.  Opposite impact of Methylene tetrahydrofolate reductase C677T and Methylene tetrahydrofolate reductase A1298C gene polymorphisms on systemic inflammation.

Authors:  Koroush Khalighi; Gang Cheng; Seyedabbas Mirabbasi; Bahar Khalighi; Yin Wu; Wuqiang Fan
Journal:  J Clin Lab Anal       Date:  2018-02-03       Impact factor: 2.352

3.  MTHFR gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis based on 16 studies.

Authors:  Zahra Bagheri-Hosseinabadi; Danyal Imani; Hassan Yousefi; Mitra Abbasifard
Journal:  Clin Rheumatol       Date:  2020-03-14       Impact factor: 2.980

4.  Combined genotype and haplotype distributions of MTHFR C677T and A1298C polymorphisms: A cross-sectional descriptive study of 13,473 Chinese adult women.

Authors:  Shujun Fan; Boyi Yang; Xueyuan Zhi; Yanxun Wang; Quanmei Zheng; Guifan Sun
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR).

Authors:  Xianchao An; Zonglin Yang; Zhengzhuang An
Journal:  Med Sci Monit       Date:  2017-05-16

6.  Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis.

Authors:  Shengli Wang; Shuguang Zuo; Zhigang Liu; Xinying Ji; Zhenqiang Yao; Xinchun Wang
Journal:  J Int Med Res       Date:  2019-10-16       Impact factor: 1.671

Review 7.  Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks.

Authors:  Shanel Raghubeer; Tandi E Matsha
Journal:  Nutrients       Date:  2021-12-20       Impact factor: 5.717

8.  The methylenetetrahydrofolate reductase 677T-1298C haplotype is a risk factor for acute lymphoblastic leukemia in children.

Authors:  Ewelina Maria Kałużna; Ewa Strauss; Bogna Świątek-Kościelna; Olga Zając-Spychała; Ewelina Gowin; Jerzy S Nowak; Jolanta Rembowska; Danuta Januszkiewicz-Lewandowska
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension: A double-blinded, randomized clinical cohort study.

Authors:  Song Zhang; Tianxun Wang; Huaiqi Wang; Jianping Tang; Ailin Hou; Xiaoling Yan; Baozhong Yu; Shuangming Ran; Min Luo; Ying Tang; Ruohan Yang; Dongsheng Song; Hanjun He
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.